Cognitive dysfunction in schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 6, 2012, Pages 491-498

  Tanaka, Tsunehiko ^a,c   Tomotake, Masahito ^a   Ueoka, Yoshinori ^a   Kaneda, Yasuhiro ^b   Taniguchi, Kyoko ^a   Nakataki, Masahito ^a   Numata, Shusuke ^a   Tayoshi, Shinya ^a   Yamauchi, Ken ^d   Sumitani, Satsuki ^a   Ohmori, Takashi ^a   Ueno, Shu Ichi ^e   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Iwaki Clinic   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d Yamauchi Clinic   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cognitive function; extrapyramidal symptom; schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; EXECUTIVE FUNCTION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; VERBAL MEMORY; WORKING MEMORY; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSKINESIA; JAPAN; MENTAL FUNCTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; SHORT TERM MEMORY; VERBAL BEHAVIOR;

ADULT; COGNITION DISORDERS; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSKINESIA, DRUG-INDUCED; EXECUTIVE FUNCTION; FEMALE; HUMANS; JAPAN; MALE; MEMORY, SHORT-TERM; MENTAL PROCESSES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIC PSYCHOLOGY; VERBAL BEHAVIOR; YOUNG ADULT;

EID: 84867526109     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2012.02390.x     Document Type: Article

References (42)

1. Kraus MS, Keefe RSE,. Cognition as an outcome measure in schizophrenia. Br. J. Psychiatry 2007; 191: 46-51.
2. Keefe RSE, Poe M, Walker TM, Harvey PD,. The Relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J. Clin. Exp. Neuropsychol. 2006; 28: 260-269. (Pubitemid 43254518)
3. Yamauchi K, Aki H, Tomotake M, et al,. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin. Neurosci. 2008; 62: 404-411.
4. Ueoka Y, Tomotake M, Tanaka T, et al,. Quality of life and cognitive dysfunction in people with schizophrenia. Prog. Neuropsychopharmacol Biol. Psychiatry 2011; 35: 53-59.
5. Heinrichs RW, Zakzanis KK,. Neurocognitive deficits in schizophrenia; A quantitative review of the evidence. Neuropsychology 1998; 12: 426-445. (Pubitemid 28323862)
6. Glahn DC, Bearden CE, Barguil M, et al,. The neurocognitive signature of psychotic bipolar disorder. Biol. Psychiatry 2007; 62: 910-916. (Pubitemid 47488219)
7. Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L,. The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004; 68: 283-297. (Pubitemid 38526150)
8. Matsuoka H,. Clinical issues of cognitive dysfunction in schizophrenia. Jpn J. Clin. Psychopharmacol. 2007; 10: 1153-1160 (in Japanese).
9. Savilla K, Kettler L, Galletly C,. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust. N. Z. J. Psychiatry 2008; 42: 496-504. (Pubitemid 351891128)
10. Thurston-Snoha BJ, Lewine RR,. Intact Wisconsin Card Sorting Test performance: Implications for the role of executive function in schizophrenia. Br. J. Clin. Psychol. 2007; 46: 361-369. (Pubitemid 47322830)
11. Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Millist L, White O,. Inhibitory control and spatial working memory: A saccadic eye movement study of negative symptoms in schizophrenia. Psychiatry Res. 2008; 157: 9-19. (Pubitemid 350166542)
12. Hughes C, Kumari V, Soni W, et al,. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr. Res. 2003; 59: 137-146. (Pubitemid 35284687)
13. Minzenberg MJ, Poole JH, Benton C, Vinogradov S,. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am. J. Psychiatry 2004; 161: 116-124. (Pubitemid 38419316)
14. Peuskens J, Demily C, Thibaut F,. Treatment of cognitive dysfunction in schizophrenia. Clin. Ther. 2005; 27: 25-37.
15. Wciõrka J, Bembenek A, Hintze B, Kühn-Dymecka A,. Schizophrenic disorders-does cognitive dysfunction relate to characteristics of course and psychopathology of the illness? Psychiatr. Pol. 2006; 40: 867-884. (Pubitemid 44763660)
16. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt PM,. A neural systems approach to the cognitive psychology of aging: Studies with CANTAB on a large sample of the normal elderly population. In:, Rabbitt PM, (ed.). Methodology of Frontal and Executive Function. Lawrence Erlbaum Associates, Hove, 1996; 215-238.
17. Hunter R, Cameron S, Perks S, Wesnes K,. The cognitive profile of unmedicated schizophrenic patients in relation to controls. J. Psychopharmacol. 1997; 11 (Suppl.): A74.
18. Cogtest plc. Cogtest(tm): Computerised Cognitive Battery for Clinical Trials. 2002. [Cited 8 Nov 2002.] Available from URL: http://www.cogtest.com
19. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK,. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004; 72: 29-39. (Pubitemid 39452903)
20. Twamley EW, Woods SP, Zurhellen CH, et al,. Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia. Schizophr. Res. 2008; 106: 42-49.
21. Tschacher W, Dubouloz P, Meier R, Junghan U,. Altered perception of apparent motion in schizophrenia spectrum disorder. Psychiatry Res. 2008; 159: 290-299.
22. Boldrini M, Del Pace L, Placidi GP, et al,. Selective cognitive deficits in obsessive-compulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr. Scand. 2005; 111: 150-158. (Pubitemid 40293183)
23. Bralet MC, Falissard B, Neveu X, Lucas-Ross M, Eskenazi AM, Keefe RS,. Validation of French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenia patients. Eur. Psychiatry 2007; 22: 365-370. (Pubitemid 47398942)
24. Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T,. Brief assessment of cognition in schizophrenia: Validation of the Japanese version. Psychiatry Clin. Neurosci. 2007; 6: 602-609. (Pubitemid 350233482)
25. Kaneda Y, Sumiyoshi T, Nakagome K, et al,. The Brief Assessment of Cognition in Schizophrenia Japanese version (BACS-J). Seishin Igaku (Clinical Psychiatry) 2008; 50: 913-917 (in Japanese).
26. Kay SR, Fiszbein A, Opler LA,. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13: 261-276. (Pubitemid 18039085)
27. Kay SR, Opler LA, Fiszbein A,. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Seiwa Pub, Tokyo, 1991.
28. Addington D, Addington J, Maticka-Tyndale E,. Assessing depression in schizophrenia: The Calgary Depression Scale. Br. J. Psychiatry 1993; 22: 39-44. (Pubitemid 23355888)
29. Kaneda Y, Fujii A, Ohmori T,. Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics. J. Nerv. Ment. Dis. 2000; 188: 237-239. (Pubitemid 30210866)
30. Inada T,. Evaluation and Diagnosis of Drug-Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to Its Usage. Seiwa Pub, Tokyo, 1996 (in Japanese).
31. Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M,. Cognitive functioning related to quality of life in schizophrenia. Prog. Neuropsychopharmacol Biol. Psychiatry 2008; 32: 280-287.
32. Klingberg S, Wittorf A, Wiedemann G,. Disorganization and cognitive impairment in schizophrenia: Independent symptom dimensions? Eur. Arch. Psychiatry Clin. Neurosci. 2006; 256: 532-540. (Pubitemid 46020527)
33. Villalta-Gil V, Vilaplana M, Ochoa S, et al,.; NEDENA Group. Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients? Schizophr. Res. 2006; 87: 246-253. (Pubitemid 44467857)
34. Bozikas VP, Kosmidis MH, Kioperlidou K, Karavatos A,. Relationship between psychopathology and cognitive functioning in schizophrenia. Compr. Psychiatry 2004; 45: 392-400. (Pubitemid 39140893)
35. Lindsberg J, Poutiainen E, Kalska H,. Clarifying the diversity of first-episode psychosis: Neuropsychological correlates of clinical symptoms. Nord. J. Psychiatry 2009; 14: 1-8.
36. Daban C, Amado I, Bourdel MC, et al,. Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J. Psychiatr. Res. 2005; 39: 391-398. (Pubitemid 40404088)
37. Sachdev P, Hume F, Toohey P, Doutney C,. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia. Acta Psychiatr. Scand. 1996; 93: 451-459. (Pubitemid 26226198)
38. Palmer BW, Heaton RK, Jeste DV,. Extrapyramidal symptoms and neuropsychological deficits in schizophrenia. Biol. Psychiatry 1999; 15: 791-794. (Pubitemid 29159057)
39. Kishi T, Moriwaki M, Kawashima K, et al,. Investigation of clinical factors influencing cognitive function in Japanese schizophrenia. Neurosci. Res. 2010; 66: 340-344.
40. Woon PS, Chia MY, Chan WY, Sim K,. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog. Neuropsychopharmacol Biol. Psychiatry 2010; 34: 463-468.
41. Seghers JP, Docherty NM,. Cognitive impairments, emotion, stress, and language in schizophrenia. Psychiatry Res. 2009; 170: 97-102.
42. Mutsatsa SH, Joyce EM, Hutton SB, Barnes TR,. Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: The West London first episode study. Eur. Arch. Psychiatry Clin. Neurosci. 2006; 256: 356-363. (Pubitemid 44393003)